Long-Term Management and Therapeutic Sequencing for Patients with Relapsing Multiple Sclerosis in France: A Vignette Study
These findings suggest that the management of RMS in France has shifted in recent years towards a desire to achieve earlier and more effective control of disease activity for people with RMS. Better guidance on the sequencing of DMTs for different scenarios within the overall management of RMS may be warranted. This study offers valuable insights into the current practices of French neurologists in managing RMS, emphasizing the complexity of therapeutic decisions, the diversity of strategies, and the significance of an individualized approach in treatment management.
Authors
- Jerome De Seze (ORCID: https://orcid.org/0000-0002-7197-7578)
- Patrick Vermersch (ORCID: https://orcid.org/0000-0003-0997-8817)
- Baptiste Roux
- Xavier Moisset (ORCID: https://orcid.org/0000-0002-8799-0750)
- Anthony Lecomte
- Laura Luciani
- Martine Paret
Institutions
- Inserm (FR)
- Université Clermont Auvergne (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Merck Serono S.A.S. (France) (FR)
- Forests and Societies (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-03-23
- DOI
- https://doi.org/10.1007/s40120-025-00726-w
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94